1. Expression analysis of inflammasome sensors and implication of NLRP12 inflammasome in prostate cancer.
    Dev Karan et al, 2017, Sci Rep CrossRef
  2. NLRP3 inflammasome activation promotes inflammation-induced carcinogenesis in head and neck squamous cell carcinoma
    Cong-Fa Huang et al, 2017, J Exp Clin Cancer Res CrossRef
  3. In Search of a Converging Cellular Mechanism in Nanotoxicology and Nanomedicine in the Treatment of Cancer
    Mary Gulumian et al, 2017, Toxicol Pathol CrossRef
  4. Resveratrol Attenuates Early Brain Injury after Experimental Subarachnoid Hemorrhage via Inhibition of NLRP3 Inflammasome Activation
    Xiangsheng Zhang et al, 2017, Front. Neurosci. CrossRef
  5. The IL-1 family of cytokines. Do they have a role in scleroderma fibrosis?
    Carol M. Artlett, 2017, Immunology Letters CrossRef
  6. NLRP3 Inflammasome Inhibition Attenuates Silica-Induced Epithelial to Mesenchymal Transition (EMT) in Human Bronchial Epithelial Cells
    Xiang Li et al, 2017, Experimental Cell Research CrossRef
  7. Inflammasomes, the cardinal pathology mediators are activated by pathogens, allergens and mutagens: A critical review with focus on NLRP3
    Seema Patel, 2017, Biomedicine & Pharmacotherapy CrossRef
  8. Luteoloside Inhibits Proliferation and Promotes Intrinsic and Extrinsic Pathway-Mediated Apoptosis Involving MAPK and mTOR Signaling Pathways in Human Cervical Cancer Cells
    Junli Shao et al, 2018, IJMS CrossRef
  9. The correlation of NLRC3 expression to the progression and prognosis of hepatocellular carcinoma
    Ying-Yu Ma et al, 2018, Human Pathology CrossRef
  10. null
    Saleela M. Ruwanpura et al, 2018 CrossRef
  11. Polydatin suppresses proliferation and metastasis of non-small cell lung cancer cells by inhibiting NLRP3 inflammasome activation via NF-κB pathway
    Jun Zou et al, 2018, Biomedicine & Pharmacotherapy CrossRef
  12. The Beta-Hydroxybutyrate Suppresses the Migration of Glioma Cells by Inhibition of NLRP3 Inflammasome
    Sen Shang et al, 2018, Cell Mol Neurobiol CrossRef
  13. Role of the NLRP3 inflammasome in cancer.
    Maryam Moossavi et al, 2018, Mol Cancer CrossRef
  14. Ergosterol peroxide from marine fungus Phoma sp. induces ROS-dependent apoptosis and autophagy in human lung adenocarcinoma cells
    Han-Ying Wu et al, 2018, Sci Rep CrossRef
  15. Inflammasomes: Emerging Central Players in Cancer Immunology and Immunotherapy
    Dev Karan, 2018, Front. Immunol. CrossRef
  16. Growth of breast cancer cells by leptin is mediated via activation of the inflammasome: Critical roles of estrogen receptor signaling and reactive oxygen species production
    Pawan Kumar Raut et al, 2019, Biochemical Pharmacology CrossRef
  17. NLRP3 deletion inhibits inflammation-driven mouse lung tumorigenesis induced by benzo(a)pyrene and lipopolysaccharide
    Li Huang et al, 2019, Respir Res CrossRef
  18. Nox1/Ref-1-Mediated Activation of CREB Promotes Gremlin1-Driven Endothelial Cell Proliferation & Migration
    Daniel S. de Jesus et al, 2019, Redox Biology CrossRef
  19. LXRα promotes cell metastasis by regulating the NLRP3 inflammasome in renal cell carcinoma
    KeShan Wang et al, 2019, Cell Death Dis CrossRef
  20. miR-16 inhibits NLRP3 inflammasome activation by directly targeting TLR4 in acute lung injury
    Yuan Yang et al, 2019, Biomedicine & Pharmacotherapy CrossRef
  21. Diverging inflammasome signals in tumorigenesis and potential targeting.
    Rajendra Karki et al, 2019, Nat Rev Cancer CrossRef
  22. Is mitochondrial dysfunction a driving mechanism linking COPD to nonsmall cell lung carcinoma?
    Francois Ng Kee Kwong et al, 2017, Eur Respir Rev CrossRef
  23. AIM2 promotes non-small-cell lung cancer cell growth through inflammasome-dependent pathway.
    Minda Zhang et al, 2019, J Cell Physiol CrossRef
  24. NOD-like receptor signaling in inflammation-associated cancers: From functions to targeted therapies.
    Peng Liu et al, 2019, Phytomedicine CrossRef
  25. The platelet NLRP3 inflammasome is upregulated in a murine model of pancreatic cancer and promotes platelet aggregation and tumor growth
    Brian A. Boone et al, 2019, Ann Hematol CrossRef
  26. Correlation Between the NLRP3 Inflammasome and the Prognosis of Patients With LSCC
    Yi Xue et al, 2019, Front. Oncol. CrossRef
  27. The Multifaceted Roles of Pyroptotic Cell Death Pathways in Cancer
    Man Wang et al, 2019, Cancers CrossRef
  28. Transcriptional regulation of inflammasome-associated pattern recognition receptors, and the relevance to disease pathogenesis
    Virginie Deswaerte et al, 2017, Molecular Immunology CrossRef
  29. Inflammasomes: Key Mediators of Lung Immunity
    Judie A. Howrylak et al, 2017, Annu. Rev. Physiol. CrossRef
  30. Airborne particulate matter in vitro exposure induces cytoskeleton remodeling through activation of the ROCK-MYPT1-MLC pathway in A549 epithelial lung cells
    Yolanda I. Chirino et al, 2017, Toxicology Letters CrossRef
  31. Is NLRP3 or NLRP6 inflammasome activation associated with inflammation-related lung tumorigenesis induced by benzo(a)pyrene and lipopolysaccharide?
    Min Gao et al, 2019, Ecotoxicology and Environmental Safety CrossRef
  32. NLRP3 participates in the regulation of EMT in bleomycin-induced pulmonary fibrosis.
    Rui Tian et al, 0 CrossRef
  33. The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma.
    Xiaodong Feng et al, 0 CrossRef
  34. The association of aberrant expression of NLRP3 and p-S6K1 in colorectal cancer
    Bin Wang et al, 2019, Pathology - Research and Practice CrossRef
  35. Opportunities and Challenges of the Human Microbiome in Ovarian Cancer
    Huiyan Cheng et al, 2020, Front. Oncol. CrossRef
  36. Insulin-like growth factor-I activates NFκB and NLRP3 inflammatory signalling via ROS in cancer cells
    Chao Wang et al, 2020, Molecular and Cellular Probes CrossRef
  37. Caffeic Acid Phenethyl Ester Prevents Colitis-Associated Cancer by Inhibiting NLRP3 Inflammasome.
    Guoliang Dai et al, 2020, Front Oncol CrossRef
  38. Targeting CREB-binding protein overrides LPS induced radioresistance in non-small cell lung cancer cell lines
    Mira Y. Gökyildirim et al, 2018, Oncotarget CrossRef
  39. Chikusetsu saponin IVa ameliorates high fat diet-induced inflammation in adipose tissue of mice through inhibition of NLRP3 inflammasome activation and NF-κB signaling
    Chengfu Yuan et al, 2017, Oncotarget CrossRef
  40. Ginkgolide B inhibits lung cancer cells promotion via beclin-1-dependent autophagy
    Xuan Wang et al, 2020, BMC Complement Med Ther CrossRef
  41. The NLRP3 Inflammasome as a Critical Actor in the Inflammaging Process
    Maria Sebastian-Valverde et al, 2020, Cells CrossRef
  42. NLRP3 Inflammasome Activation in Cancer: A Double-Edged Sword
    Shaima'a Hamarsheh et al, 2020, Front. Immunol. CrossRef
  43. NLRP3 in human glioma is correlated with increased WHO grade, and regulates cellular proliferation, apoptosis and metastasis via epithelial-mesenchymal transition and the PTEN/AKT signaling pathway
    Xiao-Feng Yin et al, 2018, Int J Oncol CrossRef
  44. Crystalline silica particles cause rapid NLRP3-dependent mitochondrial depolarization and DNA damage in airway epithelial cells
    Rongrong Wu et al, 2020, Part Fibre Toxicol CrossRef
  45. NLRP3 Inflammasome From Bench to Bedside: New Perspectives for Triple Negative Breast Cancer
    Margherita Sonnessa et al, 2020, Front. Oncol. CrossRef
  46. Features of regulation and function of inflammasomes in inflammatory diseases of the female reproductive system
    G.I. Tabeeva et al, 2020, Clin. Exp. Morphology CrossRef
  47. AKT Regulates NLRP3 Inflammasome Activation by Phosphorylating NLRP3 Serine 5
    Wei Zhao et al, 2020, J.I. CrossRef
  48. Serum amyloid A and inflammasome activation: A link to breast cancer progression?
    Carla Fourie et al, 2020, Cytokine & Growth Factor Reviews CrossRef
  49. Inflammasome Activation in Pollution-Induced Skin Conditions
    Francesca Ferrara et al, 2021 CrossRef
  50. NLRP3 inflammasome: a new therapeutic target for high-risk reproductive disorders?
    Feng Zhou et al, 2020, Chin Med J (Engl) CrossRef
  51. Therapeutic regulation of the NLRP3 inflammasome in chronic inflammatory diseases
    Jin Kyung Seok et al, 2021, Arch. Pharm. Res. CrossRef
  52. Role of the NLRP3 Inflammasome: Insights Into Cancer Hallmarks
    Ting-Yi Lin et al, 2021, Front. Immunol. CrossRef
  53. The Endocannabinoid, Anandamide, Acts as a Novel Inhibitor of LPS-Induced Inflammasome Activation in Human Gastric Cancer AGS Cell Line: Involvement of CB1 and TRPV1 Receptors
    Sahar Sadat Sedeighzadeh et al, 2021, Mediators of Inflammation CrossRef
  54. Roles of Inflammasomes in Epstein–Barr Virus-Associated Nasopharyngeal Cancer
    Chin King Looi et al, 2021, Cancers CrossRef
  55. The pyrin inflammasome aggravates inflammatory cell migration in patients with familial Mediterranean fever
    Tayfun Hilmi Akbaba et al, 2021, Pediatr Res CrossRef
  56. NLRP3 induces the autocrine secretion of IL-1β to promote epithelial–mesenchymal transition and metastasis in breast cancer
    Yuhao Wang et al, 2021, Biochemical and Biophysical Research Communications CrossRef
  57. Zerumbone Suppresses the LPS-Induced Inflammatory Response and Represses Activation of the NLRP3 Inflammasome in Macrophages
    Chia-Cheng Su et al, 2021, Front. Pharmacol. CrossRef
  58. Glyburide attenuates B(a)p and LPS ‐induced inflammation‐related lung tumorigenesis in mice
    Mengyuan Li et al, 2021, Environmental Toxicology CrossRef
  59. Hedyotis diffusa plus Scutellaria barbata Suppress the Growth of Non-Small-Cell Lung Cancer via NLRP3/NF-Κb/MAPK Signaling Pathways
    Ya-Xin Lv et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
  60. NLRP3 Inflammasome Promotes the Progression of Acute Myeloid Leukemia via IL-1β Pathway
    Chaoqing Zhong et al, 2021, Front. Immunol. CrossRef
  61. Pyroptosis in Cancer: Friend or Foe?
    Xiuxia Lu et al, 2021, Cancers CrossRef
  62. Salidroside Suppresses the Proliferation and Migration of Human Lung Cancer Cells through AMPK-Dependent NLRP3 Inflammasome Regulation
    Weidong Ma et al, 2021, Oxidative Medicine and Cellular Longevity CrossRef
  63. A novel pyroptosis-related lncRNA signature for prognostic prediction in patients with lung adenocarcinoma.
    Jiahang Song et al, 2021, Bioengineered CrossRef
  64. Identification and Validation of the Pyroptosis-Related Molecular Subtypes of Lung Adenocarcinoma by Bioinformatics and Machine Learning
    Le-Ping Liu et al, 2021, Front. Cell Dev. Biol. CrossRef
  65. NLRP3 Inflammasome Activation Enhances ADK Expression to Accelerate Epilepsy in Mice
    Haiju Zhang et al, 2021, Neurochem Res CrossRef
  66. A Novel Pyroptosis-Related Signature for Predicting Prognosis and Indicating Immune Microenvironment Features in Osteosarcoma
    Yiming Zhang et al, 2021, Front. Genet. CrossRef
  67. Ketoprofen and Loxoprofen Platinum(IV) Complexes Displaying Antimetastatic Activities by Inducing DNA Damage, Inflammation Suppression, and Enhanced Immune Response
    Zuojie Li et al, 2021, J. Med. Chem. CrossRef
  68. Development of a Prognostic Model of Glioma Based on Pyroptosis-Related Genes
    Xiaochen Niu et al, 2021, World Neurosurgery CrossRef
  69. An Integrative Network Approach to Identify Common Genes for the Therapeutics in Tuberculosis and Its Overlapping Non-Communicable Diseases
    Aftab Alam et al, 2022, Front. Pharmacol. CrossRef
  70. The role of α5-nicotinic acetylcholine receptor/NLRP3 signaling pathway in lung adenocarcinoma cell proliferation and migration
    Ying Jia et al, 2022, Toxicology CrossRef
  71. The Interplay of Hypoxia Signaling on Mitochondrial Dysfunction and Inflammation in Cardiovascular Diseases and Cancer: From Molecular Mechanisms to Therapeutic Approaches
    Esmaa Bouhamida et al, 2022, Biology CrossRef
  72. Identification of a novel prognostic signature related to PANoptosis and its regulatory mechanism as well as targeted treatment of active ingredients and traditional Chinese medicine in lung adenocarcinoma
    Shaohui Wang et al, 2022, Pharmacological Research - Modern Chinese Medicine CrossRef
  73. Pan-cancer analyses of pyroptosis with functional implications for prognosis and immunotherapy in cancer
    Aibin Liu et al, 2022, J Transl Med CrossRef
  74. The role of pyroptosis in lung cancer and compounds regulated pyroptosis of lung cancer cells
    Feng Tian et al, 2021, J Can Res Ther CrossRef
  75. Comprehensive molecular analysis of a four-pyroptosis-gene signature with prognosis and immune landscape in lung adenocarcinoma
    Shize Pan et al, 2022, Genomics CrossRef
  76. Sestrin2 in cancer: a foe or a friend?
    Moein Ala, 2022, Biomark Res CrossRef
  77. Uterus globulin associated protein 1 (UGRP1) binds podoplanin (PDPN) to promote a novel inflammation pathway during Streptococcus pneumoniae infection.
    Lei Han et al, 2022, Clin Transl Med CrossRef
  78. Mitophagy Induction and Aryl Hydrocarbon Receptor-Mediated Redox Signaling Contribute to the Suppression of Breast Cancer Cell Growth by Taloxifene via Regulation of Inflammasomes Activation
    Van Thi-Hong Tran et al, 2022, Antioxidants & Redox Signaling CrossRef
  79. Novel Inflammasome-Based Risk Score for Predicting Survival and Efficacy to Immunotherapy in Early-Stage Non-Small Cell Lung Cancer
    Chih-Cheng Tsao et al, 2022, Biomedicines CrossRef
  80. Ubiquitination as a key regulatory mechanism for O3-induced cutaneous redox inflammasome activation
    Francesca Ferrara et al, 2022, Redox Biology CrossRef
  81. Signature based on RNA-binding protein-related genes for predicting prognosis and guiding therapy in non-small cell lung cancer
    Ti-Wei Miao et al, 2022, Front. Genet. CrossRef
  82. Hesperetin from Root Extract of Clerodendrum petasites S. Moore Inhibits SARS-CoV-2 Spike Protein S1 Subunit-Induced NLRP3 Inflammasome in A549 Lung Cells via Modulation of the Akt/MAPK/AP-1 Pathway
    Punnida Arjsri et al, 2022, IJMS CrossRef
  83. Design, Synthesis, and Biological Evaluation of Dual-Target COX-2/CYP51 Inhibitors for the Treatment of Fungal Infectious Diseases
    Wenxia Liu et al, 2022, J. Med. Chem. CrossRef
  84. Neutrophil Extracellular Traps (NETs) Promote Non-Small Cell Lung Cancer Metastasis by Suppressing lncRNA MIR503HG to Activate the NF-κB/NLRP3 Inflammasome Pathway
    Yong Wang et al, 2022, Front. Immunol. CrossRef
  85. AIM2 upregulation promotes metastatic progression and PD‐L1 expression in lung adenocarcinoma
    Jing‐Quan Zheng et al, 2022, Cancer Science CrossRef
  86. MiR-223-3p attenuates the migration and invasion of NSCLC cells by regulating NLRP3
    Shasha Zhu et al, 2022, Front. Oncol. CrossRef
  87. Uncovering the Anticancer Potential of Polydatin: A Mechanistic Insight
    Muhammad Ajmal Shah et al, 2022, Molecules CrossRef
  88. IL-17A Promotes the Migration, Invasion and the EMT Process of Lung Cancer Accompanied by NLRP3 Activation
    Wenping Liu et al, 2022, BioMed Research International CrossRef
  89. Differential expression of immune-regulatory proteins C5AR1, CLEC4A and NLRP3 on peripheral blood mononuclear cells in early-stage non-small cell lung cancer patients
    Nussara Pakvisal et al, 2022, Sci Rep CrossRef
  90. Phenolic diterpenes from Rosemary supercritical extract inhibit non-small cell lung cancer lipid metabolism and synergise with therapeutic drugs in the clinic
    Adrián Bouzas et al, 2022, Front. Oncol. CrossRef
  91. Tumor-intrinsic NLRP3-HSP70-TLR4 axis drives premetastatic niche development and hyperprogression during anti–PD-1 immunotherapy
    Balamayooran Theivanthiran et al, 2022, Sci. Transl. Med. CrossRef
  92. Detection and analysis of lung microbiota in mice with lung cancer lacking the NLRP3 gene
    Xinyan Li et al, 2022, Biochemical and Biophysical Research Communications CrossRef
  93. Implications of reactive oxygen species in lung cancer and exploiting it for therapeutic interventions
    K. N. ArulJothi et al, 2022, Med Oncol CrossRef
  94. Activation of NLRP3 inflammasome in lung epithelial cells triggers radiation-induced lung injury
    Xinrui Rao et al, 2023, Respir Res CrossRef
  95. Prospects of human microbiome study for better understanding of ovarian cancer pathogenesis
    A.U. Khamadyanova et al, 2023, Ross. vestn. akush.-ginekol. CrossRef
  96. Myeloid-cell-specific role of Gasdermin D in promoting lung cancer progression in mice
    C. Alicia Traughber et al, 2023, iScience CrossRef
  97. Chrysophanol inhibits the progression of gastric cancer by activating nod-like receptor protein-3
    BINFEN HOU et al, 2023 CrossRef
  98. Inflammasomes driven inflammation in lung cancer revisited: a short review
    Vitor Rodrigues da Costa et al, 2023, Explor Immunol CrossRef
  99. Involvement of inflammasomes in tumor microenvironment and tumor therapies
    Ziqi Zhang et al, 2023, J Hematol Oncol CrossRef
  100. Identification of a Novel Prognostic Signature Related to PANoptosis and Its Regulatory Mechanism as Well as Targeted Treatment of Active Ingredients and Traditional Chinese Medicine in Lung Adenocarcinoma
    Shaohui Wang et al, 2022, SSRN Journal CrossRef
  101. Novel Activity of ODZ10117, a STAT3 Inhibitor, for Regulation of NLRP3 Inflammasome Activation
    Ju-Hui Kang et al, 2023, IJMS CrossRef
  102. NLRP3 inflammasome-induced pyroptosis in digestive system tumors
    Jiexia Wen et al, 2023, Front. Immunol. CrossRef
  103. Pyroptosis and its role in cancer
    Shi-Wei Liu et al, 2023, World J Clin Cases CrossRef
  104. Progress in the study of molecular mechanisms of cell pyroptosis in tumor therapy
    Dong Wang et al, 2023, International Immunopharmacology CrossRef
  105. Pyroptosis: A promising target for lung cancer therapy
    Wensheng Zhou et al, 2023, Chinese Medical Journal Pulmonary and Critical Care Medicine CrossRef
  106. Pyroptosis-related genes prognostic model for predicting targeted therapy and immunotherapy response in soft tissue sarcoma
    Mengmeng Liu et al, 2023, Front. Pharmacol. CrossRef
  107. Targeting Spike Glycoprotein S1 Mediated by NLRP3 Inflammasome Machinery and the Cytokine Releases in A549 Lung Epithelial Cells by Nanocurcumin
    Chuda Chittasupho et al, 2023, Pharmaceuticals CrossRef
  108. Clonal Hematopoiesis: Updates and Implications at the Solid Tumor-Immune Interface
    Marco M. Buttigieg et al, 2023, JCO Precision Oncology CrossRef
  109. NR1D1 deficiency in the tumor microenvironment promotes lung tumor development by activating the NLRP3 inflammasome
    Sun Mi Kim et al, 2023, Cell Death Discov. CrossRef
  110. IL-17A functions and the therapeutic use of IL-17A and IL-17RA targeted antibodies for cancer treatment
    Meiying Song et al, 2023, International Immunopharmacology CrossRef
  111. Machine Learning-Based Integration Develops a Macrophage-Related Index for Predicting Prognosis and Immunotherapy Response in Lung Adenocarcinoma
    Zuwei Li et al, 2023, Archives of Medical Research CrossRef
  112. Pyroptosis: shedding light on the mechanisms and links with cancers
    Hong-mei You et al, 2023, Front. Immunol. CrossRef
  113. New prospects of cancer therapy based on pyroptosis and pyroptosis inducers
    Qiaoyun Chen et al, 2023, Apoptosis CrossRef
  114. Suppression of inflammation-induced lung cancer cells proliferation and metastasis by exiguaflavanone A and exiguaflavanone B from Sophora exigua root extract through NLRP3 inflammasome pathway inhibition
    Punnida Arjsri et al, 2023, Front. Pharmacol. CrossRef
  115. A novel necroptosis related gene signature and regulatory network for overall survival prediction in lung adenocarcinoma
    Guoyu Wang et al, 2023, Sci Rep CrossRef
  116. Ajmalicine induces the pyroptosis of hepatoma cells to exert the antitumor effect
    Zhangchi Sun et al, 2023, J Biochem & Molecular Tox CrossRef
  117. Screening of novel tumor-associated antigens for lung adenocarcinoma mRNA vaccine development based on pyroptosis phenotype genes
    Fang Zhou et al, 2024, BMC Cancer CrossRef
  118. Clinical-mediated discovery of pyroptosis in CD8+ T cell and NK cell reveals melanoma heterogeneity by single-cell and bulk sequence
    Ying Zhang et al, 2023, Cell Death Dis CrossRef
  119. Crosstalk between hypoxia-induced pyroptosis and immune escape in cancer: from mechanisms to therapy
    Seyed Mohammadmahdi Meybodi et al, 2024, Critical Reviews in Oncology/Hematology CrossRef
  120. Targeting NLRP3 Inflammasome: Structure, Function, and Inhibitors
    Shengying Lou et al, 2024, CMC CrossRef